Loading...

Jcancom's Recent CancerCompass Activity

  • Jcancom has replied to a post on the message board

    I am always on the look out for emerging new technologies that might push 3-BP over the line to mainstream use. Perhaps the below might be of some help. The ability to peer into cancer cells and identify which metabolic tricks they were using could be of significant help. The article reports on the shortcomings of targetted therapies that eventually encounter resistance. The fundamental strength of the metabolic app...

    September 13 at 2:47 AM view post
    • Jcancom has replied to a post on the message board

      Here are some brief comments. Cancer is highly dependent on Glycolysis. First day of high school biology describes how cells produce energy. There are 3 energy pathways: glycolysis, Krebs cycle, and OXPHOS. The body typically takes in glucose and turns it into ATP from ADP. Glycolysis is an ancient inefficient method of creating ATP that does not require oxygen. Strangely cancer cells rely extensively on this rout...

      August 30 at 3:00 AM view post
      • Jcancom has replied to a post on the message board

        Great idea deca1!  Welcome to the thread. Yes, the thread has been completely hopeless for quite some time now. At times I regret the whole thread because a linear style thread makes trying to find anything almost impossible. Patients really need a summary of everything they need to know in a concise and easy to understand format. This is where D's site shines. https://www.cancertreatmentsresearch.com/3bp-adm...

        August 30 at 2:40 AM view post
        • Jcancom has replied to a post on the message board

          critic, good to have you on board! The article you quoted is a goodie; I am glad that you mentioned it. "... this new therapeutic approach consisting of a direct intratumoral injection of antiglycolytic agents may represent an exciting opportunity to treat patients with pancreas cancer". This one highlights for me that there are cancers such as KRAS pancreatic cancer that can be highly glycolytic and are good candi...

          August 28 at 12:47 AM view post
          • Jcancom has replied to a post on the message board

            altern, intratumoral is a good topic to raise. I do not think that we have talked about this enough on the thread. The thread has had a never ending "discussion" about the potential of 3-BP, though it has not been clearly stated that such "discussion" really only applies to iv dosing. Directly injecting 3-BP into a tumor, one would expect, would have very considerable anti-cancer effects. A dangerous tumor lysis syn...

            August 26 at 1:26 AM view post
            • Jcancom has replied to a post on the message board

              Sorry alternmed, I am unfamiliar with 3-BP enema protocols. The Cyclodextrin 3-BP research was published a few years back, though the patent has just made it through. I wonder if Prescience will use this formulation in upcoming trials.  http://www.freepatentsonline.com/9737487.html

              August 24 at 2:12 AM view post
              • Jcancom has replied to a post on the message board

                From the above url: "... the ability to detect half to three quarters of patients with early-stage colorectal, ovarian, lung, or breast cancer provides opportunities for early detection and intervention. The survival difference between late- and early-stage disease in these cancers accounts for more than a million lives worldwide each year"  This is very startling. At no time in the modern era has cancer morta...

                August 23 at 2:12 AM view post
                • Jcancom has replied to a post on the message board

                  erniemef, Apatone?

                  August 20 at 10:10 PM view post
                  • Jcancom has replied to a post on the message board

                    Are they serious? Detecting stage I and II cancer with a blood test? http://stm.sciencemag.org/content/9/403/eaan2415.full We have already reached the count down stage to when cancer mortality collapses.

                    August 20 at 2:53 AM view post
                    • Jcancom has replied to a post on the message board

                      New 3-BP patent: US 2017/0224641 A1    This is with the other Hopkins researchers. We have been focussed more on the US 7,547,673 B2 series of patents. What caught my attention in this new patent is that they are exploring oral dosing and filling in some of the blanks for the formulation. For instance they showed how dosing could be increased in rabbits with NaHCO3 versus PBS, also the importance of ...

                      August 15 at 1:37 AM view post
                      Loading...
                      Load more activity
                      Loading more activity

                      About Jcancom

                      Jcancom has not shared any information about themselves. Send them a message to tell them you'd like to find out more about them or add them as a friend.

                      We care about your feedback. Let us know how we can improve your CancerCompass experience.